CA1047924A - Poudre de produits en emulsion - Google Patents

Poudre de produits en emulsion

Info

Publication number
CA1047924A
CA1047924A CA212,545A CA212545A CA1047924A CA 1047924 A CA1047924 A CA 1047924A CA 212545 A CA212545 A CA 212545A CA 1047924 A CA1047924 A CA 1047924A
Authority
CA
Canada
Prior art keywords
oil
emulsion
water
drug
aqueous solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA212,545A
Other languages
English (en)
Other versions
CA212545S (en
Inventor
Hitoshi Sezaki
Shozo Muranishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP48121930A external-priority patent/JPS582928B2/ja
Priority claimed from JP48121929A external-priority patent/JPS582927B2/ja
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Application granted granted Critical
Publication of CA1047924A publication Critical patent/CA1047924A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
CA212,545A 1973-10-30 1974-10-29 Poudre de produits en emulsion Expired CA1047924A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP48121930A JPS582928B2 (ja) 1973-10-30 1973-10-30 粉末製品の製造法
JP48121929A JPS582927B2 (ja) 1973-10-30 1973-10-30 フンマツセイヒンノ セイゾウホウ

Publications (1)

Publication Number Publication Date
CA1047924A true CA1047924A (fr) 1979-02-06

Family

ID=26459174

Family Applications (1)

Application Number Title Priority Date Filing Date
CA212,545A Expired CA1047924A (fr) 1973-10-30 1974-10-29 Poudre de produits en emulsion

Country Status (4)

Country Link
CA (1) CA1047924A (fr)
DE (1) DE2451568A1 (fr)
FR (1) FR2257267B1 (fr)
GB (1) GB1488522A (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2521565B1 (fr) * 1982-02-17 1985-07-05 Dior Sa Parfums Christian Melange pulverulent de constituants lipidiques et de constituants hydrophobes, procede pour le preparer, phases lamellaires lipidiques hydratees et procede de fabrication, compositions pharmaceutiques ou cosmetiques comportant des phases lamellaires lipidiques hydratees
US4655941A (en) * 1984-02-13 1987-04-07 Tomita Pharmaceutical Corp., Ltd. Method of preparing mixed electrolyte powder for bicarbonate dialysis and powder mixture formed
IL78930A0 (en) * 1985-07-29 1986-09-30 Abbott Lab Lyophilized emulsion compositions for parenteral administration
GB8607717D0 (en) * 1986-03-27 1986-04-30 Unilever Plc Hydratable powders
CA2603347C (fr) * 2005-03-31 2014-06-17 Suntory Limited Emulsions huile dans l'eau de lignans qui presentent un taux d'absorption ameliore
NL2002046C (en) * 2008-10-01 2010-04-02 Friesland Brands Bv Double emulsion and method to produce such.
CN101856018B (zh) * 2010-06-18 2011-11-23 冀京民 醚菊酯可乳化粉剂及制造方法

Also Published As

Publication number Publication date
FR2257267A1 (fr) 1975-08-08
FR2257267B1 (fr) 1979-07-27
GB1488522A (en) 1977-10-12
DE2451568A1 (de) 1975-05-07

Similar Documents

Publication Publication Date Title
US4011661A (en) Powdered emulsion product and method of production
US4960814A (en) Water-dispersible polymeric compositions
DE69023682T2 (de) Gefriergetrocknete Polymerdispersionen und ihre Anwendung zur Darstellung von Arzneimittelzubereitungen mit protrahierter Wirkstoffabgabe.
AU7553687A (en) Pharmaceutical formulation and a process for its preparation
KR910004091A (ko) 투약 디바이스와 그 제조 방법 및 사용방법
KR19980701770A (ko) 미셀 미소입자
CA1047924A (fr) Poudre de produits en emulsion
AU7392694A (en) Particles with modified physicochemical properties, their preparation and uses
KR101116899B1 (ko) 안정한 농축형 및 희석형 수중유형 에멀젼
JPH04226911A (ja) 医薬の投与に適する安定乳濁液、その製造方法および医薬として使用されるべき乳濁液
JP2003526503A (ja) ナノカプセルの形態にあるコロイド粒子の調製方法
CN104055738A (zh) 利用具有溶胶-凝胶转变特性的聚合物制备微球的方法以及由此制备的微球
CN110464707A (zh) 一种熊果酸稳定的水包油型皮克林乳液及其制备方法
JP3386349B2 (ja) 水性懸濁医薬品組成物
JPH0759481B2 (ja) 安定なる水中懸濁状農薬製剤
US6455072B1 (en) Stable aqueous dispersion of nutrients
JP2005097292A (ja) Ｗ／ｏ／ｗ型複合エマルション
CN108553417A (zh) 一种蛇床子素自乳化释药系统及其制备方法与用途
EP1227780A2 (fr) Dispersion aqueuse stable d'elements nutritifs
HU201873B (en) Process for producing lipide micromedium containing ibudilaste
KR100329336B1 (ko) 히아루론산을 이용한 단백질 약물의 서방성 미세 입자 제형
Swamy et al. Formulation and Characterization of a multiple Emulsion containing Vitamin-C
JPS582927B2 (ja) フンマツセイヒンノ セイゾウホウ
CN101437502A (zh) 用于医药和生物学目的的全氟化碳气体传递乳状液：组合物、获得其的方法和药物
JPH0499716A (ja) 注射用ｗ／ｏ／ｗ型複合エマルション及びその製造法